Erie Indemnity Co
ERIE
$253.76
-1.36%
Erie Indemnity Co is a service provider for the Erie Insurance Exchange, operating in the U.S. insurance brokerage industry. It is a key administrative partner, managing sales, underwriting, and policy issuance for a major mutual insurer.
ERIE
Erie Indemnity Co
$253.76
Investment Opinion: Should I buy ERIE Today?
Based on a synthesis of the deteriorating fundamentals, severe technical damage, and high uncertainty, the objective assessment leans towards Hold for existing investors and Avoid for new buyers. While the valuation appears cheap and the balance sheet is strong, the momentum is overwhelmingly negative, and there is no clear near-term catalyst to arrest the decline. A more prudent strategy would be to wait for evidence of margin stabilization and a technical base formation before considering an entry.
Sign up to view all
ERIE 12-Month Price Forecast
The data presents a sharp conflict between high-quality fundamentals (ROE, balance sheet) and disastrous recent performance (price, margins). The path of least resistance remains down until profitability shows concrete signs of bottoming. The risk/reward is balanced, favoring a neutral stance.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Erie Indemnity Co's 12-month outlook, with a consensus price target around $329.89 and implied upside of +30.0% versus the current price.
Average Target
$329.89
1 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
1
covering this stock
Price Range
$203 - $330
Analyst target range
Analyst coverage for Erie Indemnity is extremely limited, with data from only one analyst. The consensus estimate for EPS is $13.51, with revenue estimated at $4.26 billion. No target price or ratings distribution data is provided, indicating no sufficient analyst coverage available for a comprehensive consensus summary.
Bulls vs Bears: ERIE Investment Factors
ERIE presents a classic value trap scenario. It boasts a pristine balance sheet and high operational returns, but these strengths are overshadowed by a severe technical breakdown and a recent, sharp deterioration in profitability. The stock's deep undervaluation relative to its history is compelling, but a catalyst for recovery is not yet evident.
Bullish
- Strong Balance Sheet: Zero debt and robust free cash flow of $571M provide financial stability.
- High Profitability Metrics: ROE of 24.5% and ROA of 14.8% indicate efficient capital use.
- Attractive Forward Valuation: Forward P/E of 17.9 suggests earnings growth is anticipated.
- Solid Dividend Payer: A 1.9% dividend yield with a sustainable payout ratio of 45%.
Bearish
- Severe Price Downtrend: Stock down 40% over the past year, underperforming the market significantly.
- Sharp Decline in Profitability: Q4 net margin fell to 6.7% from 16.5% year-over-year.
- Weak Revenue Growth: Modest Q4 revenue growth of 2.9% indicates limited top-line expansion.
- High Short Interest: Short ratio of 10.3 suggests strong negative market sentiment.
ERIE Technical Analysis
The stock has been in a pronounced downtrend over the observed six-month period, with the price declining from around $314 in early October 2025 to approximately $251 by the end of March 2026. This represents a significant loss, aligning with the reported 6-month price change of -20.12% and a 1-year decline of -40.03%. Short-term performance has been weak, with the stock down 6.73% over the past month and 12.33% over the past three months, underperforming the broader market as indicated by negative relative strength figures of -1.48 and -7.70, respectively. The current price of $251.31 is positioned much closer to its 52-week low of $233.82 than its high of $434.00, indicating the stock is trading near the bottom of its annual range, which reflects substantial negative momentum and investor sentiment.
Beta
0.44
0.44x market volatility
Max Drawdown
-47.6%
Largest decline past year
52-Week Range
$234-$434
Price range past year
Annual Return
-38.8%
Cumulative gain past year
| Period | ERIE Return | S&P 500 |
|---|---|---|
| 1m | +4.6% | +0.5% |
| 3m | -9.5% | -2.1% |
| 6m | -21.8% | +4.0% |
| 1y | -38.8% | +29.5% |
| ytd | -8.7% | -0.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ERIE Fundamental Analysis
Revenue growth has been modest, with Q4 2025 revenue of $951.2 million representing a 2.93% year-over-year increase from the prior year's Q4. However, profitability has shown volatility; the Q4 2025 net margin was 6.66%, a significant drop from the 16.45% net margin in Q4 2024, indicating pressure on earnings. The company maintains a strong balance sheet with zero debt, as evidenced by a debt-to-equity ratio of 0, and generates solid cash flow, with free cash flow over the trailing twelve months reported at $570.97 million. Operational efficiency metrics are robust, with a return on equity (ROE) of 24.50% and a return on assets (ROA) of 14.81%, both indicating effective use of shareholder capital and company assets.
Quarterly Revenue
$951199000.0B
2025-12
Revenue YoY Growth
+0.02%
YoY Comparison
Gross Margin
+0.14%
Latest Quarter
Free Cash Flow
$570965000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ERIE Overvalued?
Given the company's positive net income, the primary valuation metric is the Price-to-Earnings (P/E) ratio. The trailing P/E ratio is 23.87, while the forward P/E is 17.94, suggesting the market anticipates future earnings growth. The Price-to-Sales (P/S) ratio is 3.28, and the Enterprise Value-to-Sales (EV/Sales) is 3.16. Peer comparison data is not available in the provided inputs, so a relative valuation against industry averages cannot be performed.
PE
23.9x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 20x~53x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
16.5x
Enterprise Value Multiple
Investment Risk Disclosure
The primary risk is the continuation of the severe downtrend, driven by the sharp decline in net margin from 16.45% to 6.66% in Q4. This profitability collapse, if not reversed, could pressure earnings and the dividend. Market risk is elevated, as the stock has shown extreme negative relative strength (-55.96 vs. SPY over 1 year), indicating company-specific issues beyond broader market conditions. The very high short interest (short ratio 10.3) creates the risk of a short squeeze but, more pressingly, reflects deep-seated bearish conviction. Finally, the lack of analyst coverage and transparent forward guidance increases uncertainty for investors, making it difficult to gauge the timing of a potential turnaround.
FAQ
The key risks are operational and sentiment-based. The drastic fall in net margin indicates potential underlying issues in its business with the Erie Insurance Exchange. Technically, the stock is in a severe downtrend with high short interest (short ratio 10.3), reflecting persistent selling pressure. Furthermore, minimal analyst coverage increases uncertainty regarding the company's future outlook and fair value.
A 12-month base case forecast suggests a trading range of $240 to $280, implying modest upside from the current ~$251 price, contingent on earnings stabilization. The bear case could see a retest of the 52-week low near $210 if margins worsen, while a bull case towards $300+ would require a clear profitability recovery. The probabilities are weighted towards a neutral, range-bound outcome given the current conflicting signals.
ERIE appears undervalued based on its historical trading range, now trading near its 52-week low of $233.82. The forward P/E of 17.9 is also lower than the trailing P/E of 23.9, suggesting the market has priced in lower future earnings. However, this 'undervaluation' is justified by the recent collapse in profitability, creating a value trap scenario where the stock may remain cheap if earnings do not recover.
Currently, ERIE is not a compelling buy. Despite an attractive forward P/E of 17.9 and a strong balance sheet, the stock is in a pronounced downtrend, down 40% over the past year. The sharp decline in Q4 2025 net margin to 6.66% from 16.45% raises significant concerns about near-term profitability, making it prudent to wait for stabilization before considering an investment.
ERIE is unsuitable for short-term trading due to its negative momentum and high short interest, which could lead to volatile, unpredictable moves. For long-term investors, the company's zero-debt balance sheet and high ROE of 24.5% are foundational strengths, but the investment requires a multi-year horizon to potentially realize value, assuming management can navigate the current profitability challenges.